Table 2: Association between the proliferative lesions of Brunner’s gland and the variables.

VariablesType of the Proliferative Lesion of BGStatistical result
Hamartoma Hyperplasia
n%n%p

GenderFemale480538.460.294
Male120861.54
Gastritis StatusChronic gastritis360861.540.676
Active chronic gastritis240538.46
Lymphoid HyperplasiaNo3601184.620.533
Yes240215.38
Foveolar HyperplasiaNo51001292.310.722
Yes0017.69
Gastric Mucosa InflammationNo0000-
Yes510013100
Gastric Mucosa ActivationNo360646.150.5
Yes240753.85
Gastric Mucosa MetaplasiaNo480131000.278
Yes12000
Gastric Mucosa AtrophyNo480131000.278
Yes12000
Gastric Mucosa H. pyloriNo240430.770.561
Yes360969.23
Duodenitis
Status
Chronic duodenitis51001184.620.51
Active chronic duodenitis00215.38
Site of the Proliferative Lesion of BGAnterior bulbus480323.080.046
Posterior bulbus120215.38
On both sides00861.54

VariablesType of the Proliferative Lesion of BG
nMean Min. Max. SDp

AgeBG hamartoma568.6 52 8511.930.002
BG hyperplasia1340.92 16 6313.97
Lesion diameter (mm)BG hamartoma512.8 5 309.880.0001
BG hyperplasia133.07 2 40.8

BG = Brunner’s gland, f = Fisher’s exact test, U = Mann-Whitney U test, H. pylori = Helicobacter pylori, and SD = standard deviation.